Structure determination is one of the most critical challenges in advancing drug discovery research and process development. Conducting this process swiftly and accurately allows us to obtain multiple opinions...
Column
- HOME
- Column
SPERA PHARMA will exhibit at CPHI Japan 2026, held at Tokyo Big Sight from April 21 to 23, 2026. ★CPHI Japan 2026★ Date ： April 21-23, 2026 Venue： Booth 1A-41, East Hall 5, Tokyo Big Sig...
![[Research Achievement] Research result on a novel [2+2+1] radical annulation reaction enabled by 3D ED/MicroED have been published (Joint Research with Meiji Pharmaceutical University)](https://www.spera-pharma.co.jp/wp-content/themes/spera/img/news/noimage_news.jpg)
A co-authored research paper by Keiyo Nakai and Mitsuhisa Yamano (SPERA PHARMA), together with Professor Nozomi Saito and Professor Masanori Tayu of Meiji Pharmaceutical University, has been published in The J...
A new research paper authored by Keiyo Nakai, Kuniyoshi Miki, Natsuki Hashimoto, Mitsuhisa Yamano, et al., has been published in Org. Process Res. Dev. 2025 (ASAP). Journal: Org. Process Res. ...
A new research paper authored by Keiyo Nakai, Kuniyoshi Miki, Atsushi Kaga, Ryo Anzai, Mitsuhisa Yamano, et al., has been published in Crystal Growth & Design. Journal: Crystal Growth &...
PDF download SPERA PHARMA, Inc. (headquarters: Osaka; President and Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”), today announced a strategic alliance with Mycenax Biotech Inc. (headq...
We are pleased to announce that Keiyo Nakai, Ph.D from SPERA PHARMA (Chemical R&D Laboratory) and Professor Takahiro Jomori from the University of the Ryukyus will present the results of their collaborativ...
We are pleased to announce that Dr. Atsushi Kaga from our Chemical R&D Laboratory has been invited to speak at the 1st Sino-Japanese Symposium on Process Chemistry (SJPC2025), which will be held in June 20...
2025.05.12
【Research Achievement】 A new research paper has been published in Molecular Pharmaceutics
A new research paper by Keiyo Nakai, et al. has been published in the academic journal "Molecular Pharmaceutics" of the American Chemical Society. 掲載誌: Molecular Pharmaceutics, 2025, 22, 5...
PDF download SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) and Rigaku Corporation, a Group company of Rigaku Holdings Corporation...
MORE
page top